Sort by
Refine Your Search
-
Country
-
Employer
-
Field
-
or near completion of a PhD in biochemistry specializing in structural biology with associated experience and expert knowledge in the area of drug or herbicide design. Expertise in X-ray crystallography and
-
the browser or exit your application prior to submitting, the application process will be saved as a draft. You will be able to access and complete the application through “My Draft Applications” located
-
times, and genuine career progression opportunities via the academic promotions process. About You Completion or near completion of a PhD in Pharmaceutical Sciences, Drug Delivery or related field
-
of seven research groups: Drug Transport and Delivery, Cell Signalling and Targeted therapy, Natural Products and Medicinal Chemistry, Microbiology, Clinical Pharmacy and Pharmacoepidemiology, Infection
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
nanoparticle drug delivery for cancer therapy and its application in clinical settings, PK modeling to optimize immunomodulatory cancer therapies, and designing/testing new polymer-based mRNA drug delivery
-
You A PhD in Pharmaceutical Sciences, Drug Delivery or related field. Recent research experience of working in a research laboratory on projects as a post-doctoral scientist to/towards GMP standards
-
researchers and PhD students in the wider Faculty. ExeCTU Exeter Clinical Trials Unit (ExeCTU) is a UKCRC-registered, University of Exeter supported Unit. ExeCTU works in collaboration with researchers and
-
involved in the delivery of the following research projects funded by: NCYSUR through the Australian Government, Drug and Alcohol Program: Approved research projects include the co-design and piloting
-
on antibody discovery, engineering and delivery. The successful applicants will screen therapeutic antibodies against various gut infectious diseases. The candidate antibodies will be characterized and
-
on antibody discovery, engineering and delivery. The successful applicants will screen therapeutic antibodies against various gut infectious diseases. The candidate antibodies will be characterized and